Literature DB >> 11145702

Serum amyloid P component and C-reactive protein mediate phagocytosis through murine Fc gamma Rs.

C Mold1, H D Gresham, T W Du Clos.   

Abstract

The pentraxins, serum amyloid P component (SAP) and C-reactive protein (CRP) are acute-phase serum proteins in mice and humans, respectively. Although SAP binds to DNA and chromatin and affects clearance of these autoantigens, no specific receptor for SAP has been identified. CRP is an opsonin, and we have shown that it binds to FcgammaR. Mice deficient in FcgammaR were used to assess the role of these receptors in phagocytosis by pentraxins using zymosan as a ligand. Phagocytosis of zymosan by bone marrow macrophages (BMM) was enhanced by opsonization with SAP or CRP. BMM from mice deficient in all three FcgammaR or in gamma-chain ingested unopsonized zymosan, but phagocytosis of SAP- or CRP-opsonized zymosan was not enhanced. SAP binding to BMM from gamma-chain-deficient mice was also greatly reduced, indicating little or no binding of SAP to FcgammaRII. SAP and CRP opsonized zymosan for phagocytosis by BMM from mice deficient in FcgammaRII or FcgammaRIII. SAP, but not CRP, opsonized zymosan for uptake by neutrophils that express only low levels of FcgammaRI. Together these results indicate that FcgammaRI and FcgammaRIII are receptors for SAP in the mouse. Opsonization of zymosan by CRP is mediated through FcgammaRI. Pentraxins are major proteins of the innate immune system and arose earlier in evolution than Igs. The use of FcgammaR by the pentraxins links innate and adaptive immunity and may have important consequences for processing, presentation, and clearance of the self-Ags to which these proteins bind.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11145702     DOI: 10.4049/jimmunol.166.2.1200

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay.

Authors:  K A Marr; M Koudadoust; M Black; S A Balajee
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 2.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 3.  Quality control of protein folding in extracellular space.

Authors:  Justin J Yerbury; Elise M Stewart; Amy R Wyatt; Mark R Wilson
Journal:  EMBO Rep       Date:  2005-12       Impact factor: 8.807

4.  Distinct Fcγ receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation.

Authors:  Nehemiah Cox; Darrell Pilling; Richard H Gomer
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 5.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

Review 6.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

7.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

8.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09

9.  Inhibition of Experimental Autoimmune Encephalomyelitis in Human C-Reactive Protein Transgenic Mice Is FcγRIIB Dependent.

Authors:  Xian-Zhen Hu; Tyler T Wright; Nicholas R Jones; Theresa N Ramos; Gregory A Skibinski; Mark A McCrory; Scott R Barnum; Alexander J Szalai
Journal:  Autoimmune Dis       Date:  2010-10-12

10.  Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction.

Authors:  M Bijl; H Bootsma; Y Van Der Geld; P C Limburg; C G M Kallenberg; M H Van Rijswijk
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.